Macquarie Initiates Coverage on ILUVATAR COREX with Outperform Rating and HK$1240 Target

Stock News
07/01

Macquarie has released a research report, initiating coverage on Hong Kong-listed ILUVATAR COREX (09903) with an "Outperform" investment rating and a target price of HK$1240.

The report identifies the company as a leading domestic enterprise in the field of general-purpose GPUs (GPGPU), possessing the longest development history in this sector within China.

Supported by a diverse product portfolio and a mature supply chain, the company has established itself as a strong competitor for market share in the domestic AI chip arena.

The analysis further highlights that the company's relatively extensive industry experience in GPGPU chip design and its established supply chain system form its core differentiating advantages, granting it higher operational efficiency and greater earnings predictability compared to peers.

Regarding financial projections, Macquarie anticipates the company will maintain robust revenue growth momentum, forecasting a compound annual growth rate of 120% from 2025 to 2028, with revenue expected to exceed 11 billion yuan by 2028.

On the profitability front, driven by increasing revenue scale and product mix upgrades, the company is projected to achieve a turnaround to profitability by 2027, marking the beginning of its earnings realization phase.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10